Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Thierry Conroy(Inserm), Jean François Seitz(Canadian Partnership Against Cancer), Emmanuel Mitry(Institut Paoli-Calmettes), Marion Chauvenet(Canadian Partnership Against Cancer), François‐Xavier Caroli‐Bosc(Canadian Partnership Against Cancer), Roger Faroux(Roche (Switzerland)), Méher Ben Abdelghani(Université Paris Cité), Karine Bouhier‐Leporrier(Université Paris Cité), Victoire Granger(Canadian Partnership Against Cancer), James Biagi(Université Paris Cité), Jean-Louis Legoux(Université Paris Cité), Marc Ychou(Université de Montpellier), Christian Platini(Canadian Partnership Against Cancer), Marc Pracht(Canadian Partnership Against Cancer), H. Castanie, Caroline Couffon(Canadian Partnership Against Cancer), Antoine Adenis(Inserm), Mohamed Gasmi(Canadian Partnership Against Cancer), Jaafar Bennouna(Hôpital Foch), Emmanuel Maillard(Institut de Cancérologie de l'Ouest), Eric Assénat, Anthony Turpin(Centre National de la Recherche Scientifique), Lucile Bauguion(Centre Hospitalier Départemental Vendée), Valérie Lebrun-Ly(Canadian Partnership Against Cancer), Pascal Artru(Université Paris Cité), François Ghiringhelli(Inserm), Julien Volet(Université Paris Cité), Ludovic Evesque(Centre Antoine Lacassagne), Laurent Miglianico(Canadian Partnership Against Cancer), Éric François(Centre Antoine Lacassagne), Christelle de la Fouchardière(Aix-Marseille Université), Farid El Hajbi, Pascal Hammel(Hôpital Paul-Brousse), Patrick Texereau(Université Paris Cité), Olivier Bouché(CHU Dijon Bourgogne), Aurélien Lambert(Institut de Cancérologie de Lorraine), Jean‐Frédéric Blanc, Yann Touchefeu(Canadian Partnership Against Cancer), Thierry Lecomte(Université Paris Cité), Denis Péré-Vergé(Canadian Partnership Against Cancer), Laure Monard(UniCancer Group), Rosine Guimbaud(Canadian Partnership Against Cancer), Vincent Bourgeois(Canadian Partnership Against Cancer), Alice Gagnaire(Canadian Partnership Against Cancer), Anthony Lopez, Jean‐François Ramée(Canadian Partnership Against Cancer), Alice C. Wei(Université Paris Cité), Frédéric FIORE(Canadian Partnership Against Cancer), Florence Castan(Université de Montpellier)
Cited by 322
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k